fotemustine has been researched along with T-Cell Lymphoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aloj, L; Arcamone, M; Becchimanzi, C; Capobianco, G; Corazzelli, G; De Filippi, R; Frigeri, F; Lastoria, S; Marcacci, G; Morelli, E; Pinto, A; Russo, F; Volzone, F | 1 |
1 other study(ies) available for fotemustine and T-Cell Lymphoma
| Article | Year |
|---|---|
Efficacy and safety of the third-generation chloroethylnitrosourea fotemustine for the treatment of chemorefractory T-cell lymphomas.
Topics: Aged; Antineoplastic Agents, Alkylating; Humans; Lymphoma, T-Cell; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds | 2011 |